{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:11:28Z","timestamp":1778911888423,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["4800-6634-313"],"award-info":[{"award-number":["4800-6634-313"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["2021-NI-004-00"],"award-info":[{"award-number":["2021-NI-004-00"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jvacx.2024.100437","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T02:50:18Z","timestamp":1705114218000},"page":"100437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Seo","family":"Yeon Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Ho","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dokeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeran","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvacx.2024.100437_b0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rmv.1819","article-title":"Genomic diversity of mumps virus and global distribution of the 12 genotypes","volume":"25","author":"Jin","year":"2015","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jvacx.2024.100437_b0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijid.2017.02.011","article-title":"Increasing mumps incidence rates among children and adolescents in the Republic of Korea: age\u2013period\u2013cohort analysis","volume":"57","author":"Choe","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100437_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00151-19","article-title":"Mumps: an update on outbreaks, vaccine efficacy, and genomic diversity","volume":"33","author":"Lam","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jvacx.2024.100437_b0020","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jvacx.2024.100437_b0025","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1016\/j.vaccine.2009.06.109","article-title":"Mumps resurgences in the United States: a historical perspective on unexpected elements","volume":"27","author":"Barskey","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100437_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1473-3099(18)30498-5","article-title":"A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study","volume":"19","author":"Westphal","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100437_b0035","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3389\/fimmu.2020.02089","article-title":"Mumps outbreaks in vaccinated populations\u2014is it time to reassess the clinical efficacy of vaccines?","volume":"11","author":"Connell","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2024.100437_b0040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100437_b0045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100437_b0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PHH.0000000000000962","article-title":"CDC guidance for use of a third dose of MMR vaccine during mumps outbreaks","volume":"26","author":"Marlow","year":"2020","journal-title":"J Public Health Manag Pract"},{"key":"10.1016\/j.jvacx.2024.100437_b0055","doi-asserted-by":"crossref","unstructured":"Marin M, Marlow M, Moore KL, Patel M, Morb MMWR. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. MMWR Morb Mortal Wkly Rep. 2018. Published online;67:33\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm6701a7.","DOI":"10.15585\/mmwr.mm6701a7"},{"issue":"ofu094","key":"10.1016\/j.jvacx.2024.100437_b0060","article-title":"Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine","volume":"1","author":"Fiebelkorn","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"ofx263","key":"10.1016\/j.jvacx.2024.100437_b0065","article-title":"Mumps virus nucleoprotein and hemagglutinin-specific antibody response following a third dose of measles mumps rubella vaccine","volume":"4","author":"Latner","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.jvacx.2024.100437_b0070","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/infdis\/jiz345","article-title":"Assessment of mumps virus-specific antibodies: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay estimates","volume":"220","author":"Ravault","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jvacx.2024.100437_b0075","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fmicb.2020.01999","article-title":"Mumps vaccines: current challenges and future prospects","volume":"11","author":"Almansour","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jvacx.2024.100437_b0080","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.vaccine.2021.01.039","article-title":"Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea","volume":"39","author":"Won","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100437_b0085","doi-asserted-by":"crossref","first-page":"19071","DOI":"10.1073\/pnas.1905570116","article-title":"Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood","volume":"116","author":"Rasheed","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvacx.2024.100437_b0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/vaccines11010106","article-title":"Improved immunogenicity of the inactivated F genotype mumps vaccine against diverse circulating mumps viruses in mice","volume":"11","author":"Won","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jvacx.2024.100437_b0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.virol.2021.12.003","article-title":"Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes","volume":"566","author":"Park","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.jvacx.2024.100437_b0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"WHO working group on measles plaque reduction neutralization test. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100437_b0105","doi-asserted-by":"crossref","first-page":"e0174444","DOI":"10.1371\/journal.pone.0174444","article-title":"Establishing a small animal model for evaluating protective immunity against mumps virus","volume":"12","author":"Pickar","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jvacx.2024.100437_b0110","doi-asserted-by":"crossref","unstructured":"Xu P, Huang Z, Gao X, Michel FJ, Hirsch G, Hogan RJ, et al. Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate. J Virol. 2013;87(14):8158\u201368. https:\/\/doi: 10.1128\/jvi.01028-13.","DOI":"10.1128\/JVI.01028-13"},{"key":"10.1016\/j.jvacx.2024.100437_b0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/vaccines10010132","article-title":"Antibody levels at 3-years follow-up of a third dose of measles-mumps-rubella vaccine in young adults","volume":"10","author":"Kaaijk","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.jvacx.2024.100437_b0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/JVI.06125-11","article-title":"Recent mumps outbreaks in vaccinated populations: no evidence of immune escape","volume":"86","author":"Rubin","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2024.100437_b0125","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.vaccine.2005.10.050","article-title":"Serological and phylogenetic evidence of monotypic immune responses to different mumps virus strains","volume":"24","author":"Rubin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2024.100437_b0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jvacx.2024.100437_b0135","doi-asserted-by":"crossref","first-page":"e61791","DOI":"10.1371\/journal.pone.0061791","article-title":"Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms","volume":"8","author":"Cui","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jvacx.2024.100437_b0140","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1017\/S0950268812001896","article-title":"Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies","volume":"141","author":"\u0160antak","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jvacx.2024.100437_b0145","doi-asserted-by":"crossref","first-page":"e0198321","DOI":"10.1128\/jvi.01983-21","article-title":"Immunogenicity of mumps virus genotype G vaccine candidates in Jeryl Lynn-immunized mice","volume":"96","author":"Briggs","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2024.100437_b0150","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.02778-13","article-title":"Immunogenicity of novel mumps vaccine candidates generated by genetic modification","volume":"88","author":"Xu","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jvacx.2024.100437_b0155","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s007050170088","article-title":"Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route","volume":"146","author":"Cusi","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.jvacx.2024.100437_b0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jinf.2018.03.002","article-title":"Mumps outbreaks: A problem in need of solutions","volume":"76","author":"Principi","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.jvacx.2024.100437_b0165","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/s41467-021-23173-1","article-title":"Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice","volume":"12","author":"Spencer","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jvacx.2024.100437_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.882972","article-title":"Vaccine-associated enhanced disease and pathogenic human coronaviruses","volume":"13","author":"Gartlan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2024.100437_b0175","doi-asserted-by":"crossref","first-page":"eabm0899","DOI":"10.1126\/scitranslmed.abm0899","article-title":"Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models","volume":"14","author":"Huang","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jvacx.2024.100437_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.882856","article-title":"Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro","volume":"13","author":"Luan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2024.100437_b0185","doi-asserted-by":"crossref","first-page":"e0164245","DOI":"10.1371\/journal.pone.0164245","article-title":"Complete Protection against Influenza Virus H1N1 Strain A\/PR\/8\/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines","volume":"11","author":"Rouxel","year":"2016","journal-title":"PLoS One"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259013622400010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259013622400010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:53:16Z","timestamp":1778910796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259013622400010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":37,"alternative-id":["S259013622400010X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100437","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2024.100437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100437"}}